Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
December 05, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
OTLK
Pacific Sands Educates on Alcohol Blackouts
December 05, 2023
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
December 04, 2023
Via
TheNewswire.com
Exposures
Product Safety
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
December 04, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
ETNB
Ozempic vs. Mounjaro:: Battle of the bulge
December 04, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
PFE
ExoAtlet Unveils Groundbreaking ExoAtlet 2 and Industry-First Pediatric Exoskeleton
November 29, 2023
Via
Press Release Distribution Service
Exposures
Product Safety
Actuated Medical Expands Expertise in Forensic DNA Analysis with Acquisition of Mitotyping Technologies LLC
December 05, 2023
Via
PRLog
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
December 04, 2023
Via
News Direct
Exposures
Product Safety
FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug
December 04, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
Why Is Chronic Disease Focused Biora Therapeutics Stock Trading Higher Today?
December 01, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
BIOR
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
November 30, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
OTLK
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
November 30, 2023
Via
News Direct
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
November 30, 2023
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Why Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today?
November 30, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
SNGX
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in December MedInvest Oncology Investor Conference
November 30, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
Why Is Soligenix (SNGX) Stock Up 285% Today?
November 30, 2023
Via
InvestorPlace
Exposures
Product Safety
Tickers
IMGN
MINM
QS
SNGX
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discussed ‘Breakthrough’ FDA Clearance in Proactive Interview
November 30, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VVOS
ROSEN, A LEADING AND RANKED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
November 29, 2023
Via
NewMediaWire
Topics
Lawsuit
Product Recall
Exposures
Financial
Legal
Product Safety
Tickers
SCYX
Cannabis Mold Alert In Arizona, California Nears $5.5B Tax Milestone, Search For Marijuana Breathalyzer
November 29, 2023
Via
Benzinga
Topics
Cannabis
Product Recall
Exposures
Cannabis
Legal
Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
November 29, 2023
Via
News Direct
Exposures
Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
November 29, 2023
Via
TheNewswire.com
Exposures
Product Safety
Yoonpak: Pioneering Paper Cup Manufacturers in Sustainable Packaging
November 29, 2023
Via
AB Newswire
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Shareholder Letter
November 29, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces First-Ever FDA Clearance for Treatment of Severe Obstructive Sleep Apnea Using Oral Device
November 29, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VVOS
InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Updates Special Access Program
November 29, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
MYCOF
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
November 29, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
VVOS
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
November 29, 2023
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
AAPL
TBRIF
TSX-V:THRM
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
GILD
JNJ
NVS
Distinguished author and life coach Eric North shares guidance on making the holidays happier
November 29, 2023
Via
IssueWire
Topics
Product Recall
Exposures
Legal
Product Safety
New Partnership Between Generis And Risetime Provides Easy and Compliant Information Management for Cosmetics Industry
November 29, 2023
Via
PRLog
Exposures
Product Safety
Tickers
PFE
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.